FDA says don’t use OTC teething products that contain benzocaine

Over-the-counter teething products that contain benzocaine pose a “serious risk to infants and children” and offer no benefit, according to an FDA warning. Teething gels, sprays, ointments, solutions and lozenges that contain benzocaine could cause the fatal blood condition methemoglobinemia, the FDA said, and the agency is asking manufacturers to stop marketing the products for pediatric use. USA Today (5/23) 

Leave a Reply

Your email address will not be published. Required fields are marked *